Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE

被引:16
|
作者
Branche, Brandee L. [1 ]
Howard, Lauren E. [1 ,2 ]
Moreira, Daniel M. [3 ]
Roehrborn, Claus [4 ]
Castro-Santamaria, Ramiro [5 ]
Andriole, Gerald L. [6 ]
Hopp, Martin L.
Freedland, Stephen J. [1 ,7 ]
机构
[1] Duke Univ, Sch Med, Durham Vet Affairs Med Ctr, Surg Sect, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
[3] Univ Illinois, Chicago, IL USA
[4] Univ Texas Southwestern, Med Ctr, Dallas, TX USA
[5] GlaxoSmithKline Inc, Metab Pathways & Cardiovasc R&D Unit, King Of Prussia, PA USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Cedars Sinai Med Ctr, 8635 West 3rd St,Suite 1070W, Los Angeles, CA 90048 USA
来源
JOURNAL OF UROLOGY | 2018年 / 199卷 / 02期
基金
美国国家卫生研究院;
关键词
prostate; prostatic hyperplasia; lower urinary tract symptoms; sleep; patient reported outcome measures; PROSTATE-CANCER EVENTS; OBESITY; TRIAL; DUTASTERIDE; METABOLISM; NOCTURIA; SCALE; TIME; RISK; MEN;
D O I
10.1016/j.juro.2017.08.108
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Although lower urinary tract symptoms and sleep problems often develop together, to our knowledge it is unknown whether sleep disturbances are linked to lower urinary tract symptoms development and progression. As measured by the 6-item MOS-Sleep (Medical Outcomes Study Sleep Scale) survey we examined the relationship between sleep problems, and the development and progression of lower urinary tract symptoms in the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) study. Materials and Methods: REDUCE was a randomized trial testing prostate cancer chemoprevention with dutasteride in men with prostate specific antigen 2.5 to 10 ng/ml and a negative biopsy. At baseline men completed MOS-Sleep and a scaled average was used to calculate the sleep score. Men were followed for 4 years and I-PSS (International Prostate Symptom Score) was completed at baseline and every 6 months. Asymptomatic men had I-PSS less than 8 while symptomatic men had I-PSS 8 or greater. In the placebo arm of 2,588 men not receiving a-blockers or 5a-reductase inhibitors at baseline we tested the association between sleep problems and lower urinary tract symptom development and progression using Cox models. Results: During followup lower urinary tract symptoms developed in 209 of 1,452 asymptomatic men (14%) and 580 of 1,136 (51%) with lower urinary tract symptoms demonstrated progression. On multivariable analysis higher sleep scores were suggestively associated with increased lower urinary tract symptoms in asymptomatic men (quartile 4 vs 1 HR 1.41, 95% CI 0.92-2.17, p = 0.12) and with lower urinary tract symptom progression in symptomatic men (per 10 points of sleep score HR 1.06, 95% CI 1.01-1.12, p = 0.029). Conclusions: Among men with lower urinary tract symptoms worse sleep scores were associated with the progression of lower urinary tract symptoms and among asymptomatic men worse sleep scores were suggestively associated with the development of lower urinary tract symptoms. If confirmed, these data suggest that sleep problems may precede such symptoms. Whether treating sleep problems would improve lower urinary tract symptoms requires further testing.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [41] Verumontanum Cyst Associated With Lower Urinary Tract Symptoms in an Adolescent
    Nork, Justin J.
    Yap, Mike K.
    Kaplan, George W.
    UROLOGY, 2016, 88 : 192 - 194
  • [42] Impaired Sleep Quality is Associated With More Significant Lower Urinary Tract Symptoms in Male Shift Workers
    Scovell, Jason M.
    Pastuszak, Alexander W.
    Slawin, Jeremy
    Badal, Justin
    Link, Richard E.
    Lipshultz, Larry I.
    UROLOGY, 2017, 99 : 197 - 201
  • [43] Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study
    Zuluaga, Laura
    Caicedo, Juan Ignacio
    Mogollon, Maria Paula
    Santander, Jessica
    Bravo-Balado, Alejandra
    Trujillo, Carlos Gustavo
    Diaz Ritter, Cesar
    Rondon, Martin
    Plata, Mauricio
    WORLD JOURNAL OF UROLOGY, 2023, 41 (05) : 1381 - 1388
  • [44] Anxiety and depression in association with lower urinary tract symptoms: results from the COBaLT study
    Laura Zuluaga
    Juan Ignacio Caicedo
    María Paula Mogollón
    Jessica Santander
    Alejandra Bravo-Balado
    Carlos Gustavo Trujillo
    César Diaz Ritter
    Martín Rondón
    Mauricio Plata
    World Journal of Urology, 2023, 41 : 1381 - 1388
  • [45] THE RELATIONSHIP BETWEEN SLEEP DISORDERS AND LOWER URINARY TRACT SYMPTOMS: RESULTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES)
    Fantus, Richard
    Helfand, Brian
    Wang, Chi-Hsiung
    JOURNAL OF UROLOGY, 2017, 197 (04): : E159 - E159
  • [46] URINARY PHYTOESTROGEN LEVELS ARE ASSOCIATED WITH LOWER URINARY TRACT SYMPTOMS IN POSTMENOPAUSAL WOMEN
    Kreydin, Evgeniy
    Santiago-Lastra, Yahir
    Rodriguez, Dayron
    Sanchez, Alejandro
    Keenan, Hillary
    Ko, Dicken
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 179 - 179
  • [47] SYMPTOMS OF CENTRAL SENSITIZATION ARE ASSOCIATED WITH WORSE LOWER URINARY TRACT SYMPTOMS IN MEN
    Senders, Angela
    Sajadi, Kamran
    Bauer, Scott
    Le, Thu
    Wexler, Ryan
    Chen, Yiyi
    Oken, Barry
    Marshall, Lynn
    JOURNAL OF UROLOGY, 2021, 206 : E13 - E13
  • [48] Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial
    Kramer, Jordan J.
    Gu, Lin
    Moreira, Daniel
    Andriole, Gerald
    Csizmadi, Ilona
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2022, 207 (02): : 418 - 423
  • [49] SMOKING AND INCIDENCE AND PROGRESSION OF LOWER URINARY TRACT SYMPTOMS (LUTS) IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL
    Kramer, Jordan J.
    Csizmadi, Illona
    Gu, Lin
    Moreira, Daniel
    Andriole, Gerald
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2021, 206 : E483 - E484
  • [50] Development of a Lower Urinary Tract Symptoms Guideline for Community Pharmacists
    Gabriel, G.
    Tsuyuki, R.
    Sadowski, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S261 - S262